Credit Suisse’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $104K | Sell |
36,643
-1,409
| -4% | -$4K | ﹤0.01% | 2926 |
|
|
2023
Q4 | $560K | Buy |
38,052
+3,739
| +11% | +$55K | ﹤0.01% | 2670 |
|
|
2023
Q3 | $628K | Buy |
34,313
+996
| +3% | +$18.2K | ﹤0.01% | 2556 |
|
|
2023
Q2 | $719K | Buy |
+33,317
| New | +$719K | ﹤0.01% | 2586 |
|
|
2023
Q1 | – | Sell |
-2
| Closed | -$74 | – | 3259 |
|
|
2022
Q4 | $74 | Sell |
2
-195
| -99% | -$7.22K | ﹤0.01% | 3599 |
|
|
2022
Q3 | $6K | Buy |
197
+186
| +1,691% | +$5.67K | ﹤0.01% | 3614 |
|
|
2022
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 3882 |
|